Xichuangtou

Xijia Medical (曦嘉医疗), a brain-science AI company founded in 2019, raised a Pre-A round of several million dollars (tens of millions of yuan) led by Guozhong Capital; Xichuangtou, Qinzhi Capital, Huichuang Medical, and Xingfu Capital joined. The company says its NuraTome individualized brain network atlas, built from connectomics and MRI analysis, supports neurosurgery planning, TMS navigation, and BCI electrode placement; its planning software is in 180+ institutions, used in nearly 20,000 surgeries and 20+ BCI electrode implantations. Funds go to clinical research, market expansion, and product iteration.

Xingce Future has closed A+ and A++ rounds totalling hundreds of millions of yuan (tens of millions of dollars), with investors including Beichuangtou, Meridian Capital China, Xinshang Capital and Xinding Capital. Existing investors Xichuangtou and Houtian Capital joined. Tsinghua University spinoff from the Tian Ge Project team says it has 37 advanced-process GPUs in orbit and 39 payloads running stably, including the first domestic 12nm and global 7nm GPU in-orbit applications. It announced the Fuyao Plan for a cloud-coordinated space-computing constellation and has joined national remote-sensing constellation projects.